Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Tim Frederik Weber

A Phase II Study for Metabolic in Vivo Response Monitoring With Sequential 18fdg-Pet-Ct During Treatment With the EGFR-monoclonal-antibody Cetuximab in Metastatic Colorectal Cancer: The Heidelberg REMOTUX Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Related publications

Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients With Metastatic Colorectal Cancer Treated With Irinotecan and Cetuximab

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2013English

Cetuximab Retreatment in Patients With Metastatic Colorectal Cancer Who Exhibited a Clinical Benefit in Response to Prior Cetuximab: A Retrospective Study

Oncology Letters
Cancer ResearchOncology
2018English

Dermatologic Toxicity Occurring During Anti-Egfr Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Cetuximab in First Line Treatment of Metastatic Colorectal Cancer

Farmeconomia. Health economics and therapeutic pathways
2012English

Role of 18FDG PET/CT in Breast Cancer

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Medicine
2018English

Comment on ‘Clinical Significance of BRAF Non-V600e Mutations on the Therapeutic Effects of Anti-Egfr Monoclonal Antibody Treatment in Patients With Pretreated Metastatic Colorectal Cancer: The Biomarker Research for Anti-Egfr Monoclonal Antibodies by Comprehensive Cancer Genomics (BREAC) Study’

British Journal of Cancer
Cancer ResearchOncology
2018English

Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- Or Panitumumab-Refractory Metastatic Colorectal Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Myocardial Viability Assessment in 18FDG PET/CT Study (18FDG PET Myocardial Viability Assessment)

Nuclear Medicine Review
MedicineNuclear MedicineRadiologyImaging
2012English

S‐1 Plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial

Oncologist
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy